You are here: Industry Insights > API

News List

Pharma Sources Insight January 2025: What are Reshaping Pharma's Future? Pharma Sources Insight
January 09, 2025
Pharma Sources Insight JUNE 2024 focuses on wearable delivery system, sythetic biology, pharmaceutical globalization and more.
Charting Pharma’s Future: How Mergers and Acquisitions Are Reshaping the Industry Landscape Neeta Ratanghayra
December 17, 2024
In Q3 2024 (GlobalData’s Deals Database), the pharmaceutical sector saw 420 M&A deals valued at $32.4 billion, underscoring the ongoing importance of these transactions in shaping the future of the industry.
Popular APIs of the Year at Pharmasources.com PharmaSources
December 10, 2024
What are the APIs that caught the highest attention in the year at PharmaSources.com？
Emerging Therapies and Targets to Pain Management Market Shruti Talashi
December 20, 2024
Medication used to relieve pain is known as a pain management medication. They work well for mild to moderate discomfort, When used as prescribed, it's safe, but excessive dosages or liver disease might make it poisonous.
How to Source Safe and Effective Antibiotic APIs for Pediatric Formulations Saher Haider
December 09, 2024
Given children's unique physiological and pharmacokinetic characteristics, the development of pediatric antibiotic formulations requires stringent controls.
The Rapidly Expanding Global Weight Loss Market and the Role of Chinese Innovations PharmaSources/ChatGPT
August 28, 2024
The trend highlights China’s growing influence in the global pharmaceutical landscape and its increasing role in advancing global health solutions.
SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases Biotech Newswire
July 09, 2024
The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary iRhom2 strategy.
Gut Hormone-Based Pharmacotherapies for Obesity Neeta Ratanghayra
April 28, 2024
The history of pharmacotherapy for obesity is marked by a series of promising drugs that were withdrawn due to safety concerns.
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study PharmaSources
April 07, 2024
Touchlight announced an agreement with University of Liverpool for the use of dbDNA in the development of a fully-personalised therapeuticneoantigen DNA vaccine for patients with non-small cell lung cancer.
ARCH Top-tier Pharmaceutical Venture Capital Firm: ARCH Yefenghong
March 06, 2024
The R&D of new drugs is inextricably linked to substantial financial backing. Within this framework, the role of venture capital firms is immeasurable. Today, we spotlight the renowned venture capital entity, ARCH.